Herein, we asked whether mutation status, clinicopathological background, or altered regulatory mechanisms in patients with PAAD are associated with changed laminin expression, we analysed the association between survival and mRNA expression of individual laminins, laminin combinations, and co-expressed genes, and identified predictors of therapeutic response based on laminin expression. Here, LAMB2 is linked to pancreatic adenocarcinoma.